US FDA Approves Breakthrough Pancreatic Cancer Pill After Trial Shows Survival Benefit

From Dispatch Room The United States Food and Drug Administration has approved a new targeted pancreatic cancer drug from Revolution Medicines after a major clinical trial showed a substantial survival benefit for patients with advanced disease. The once-daily pill, which will be marketed as Rasonque, was approved for patients with metastatic pancreatic cancer who have […]